203 related articles for article (PubMed ID: 37545643)
1. Caspase 3 exhibits a yeast metacaspase proteostasis function that protects mitochondria from toxic TDP43 aggregates.
Brunette S; Sharma A; Bell R; Puente L; Megeney LA
Microb Cell; 2023 Aug; 10(8):157-169. PubMed ID: 37545643
[TBL] [Abstract][Full Text] [Related]
2. Partial Failure of Proteostasis Systems Counteracting TDP-43 Aggregates in Neurodegenerative Diseases.
Cascella R; Fani G; Bigi A; Chiti F; Cecchi C
Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357627
[TBL] [Abstract][Full Text] [Related]
3. Modeling hallmark pathology using motor neurons derived from the family and sporadic amyotrophic lateral sclerosis patient-specific iPS cells.
Sun X; Song J; Huang H; Chen H; Qian K
Stem Cell Res Ther; 2018 Nov; 9(1):315. PubMed ID: 30442180
[TBL] [Abstract][Full Text] [Related]
4. Aberrant assembly of RNA recognition motif 1 links to pathogenic conversion of TAR DNA-binding protein of 43 kDa (TDP-43).
Shodai A; Morimura T; Ido A; Uchida T; Ayaki T; Takahashi R; Kitazawa S; Suzuki S; Shirouzu M; Kigawa T; Muto Y; Yokoyama S; Takahashi R; Kitahara R; Ito H; Fujiwara N; Urushitani M
J Biol Chem; 2013 May; 288(21):14886-905. PubMed ID: 23558684
[TBL] [Abstract][Full Text] [Related]
5. The debated toxic role of aggregated TDP-43 in amyotrophic lateral sclerosis: a resolution in sight?
Hergesheimer RC; Chami AA; de Assis DR; Vourc'h P; Andres CR; Corcia P; Lanznaster D; Blasco H
Brain; 2019 May; 142(5):1176-1194. PubMed ID: 30938443
[TBL] [Abstract][Full Text] [Related]
6. ALS-associated ataxin 2 polyQ expansions enhance stress-induced caspase 3 activation and increase TDP-43 pathological modifications.
Hart MP; Gitler AD
J Neurosci; 2012 Jul; 32(27):9133-42. PubMed ID: 22764223
[TBL] [Abstract][Full Text] [Related]
7. Interaction of RNA with a C-terminal fragment of the amyotrophic lateral sclerosis-associated TDP43 reduces cytotoxicity.
Kitamura A; Nakayama Y; Shibasaki A; Taki A; Yuno S; Takeda K; Yahara M; Tanabe N; Kinjo M
Sci Rep; 2016 Jan; 6():19230. PubMed ID: 26757674
[TBL] [Abstract][Full Text] [Related]
8. Extracellular TDP-43 aggregates target MAPK/MAK/MRK overlapping kinase (MOK) and trigger caspase-3/IL-18 signaling in microglia.
Leal-Lasarte MM; Franco JM; Labrador-Garrido A; Pozo D; Roodveldt C
FASEB J; 2017 Jul; 31(7):2797-2816. PubMed ID: 28336525
[TBL] [Abstract][Full Text] [Related]
9. Dipeptide repeat protein inclusions are rare in the spinal cord and almost absent from motor neurons in C9ORF72 mutant amyotrophic lateral sclerosis and are unlikely to cause their degeneration.
Gomez-Deza J; Lee YB; Troakes C; Nolan M; Al-Sarraj S; Gallo JM; Shaw CE
Acta Neuropathol Commun; 2015 Jun; 3():38. PubMed ID: 26108573
[TBL] [Abstract][Full Text] [Related]
10. Phosphorylated TDP-43 aggregates in skeletal and cardiac muscle are a marker of myogenic degeneration in amyotrophic lateral sclerosis and various conditions.
Mori F; Tada M; Kon T; Miki Y; Tanji K; Kurotaki H; Tomiyama M; Ishihara T; Onodera O; Kakita A; Wakabayashi K
Acta Neuropathol Commun; 2019 Oct; 7(1):165. PubMed ID: 31661037
[TBL] [Abstract][Full Text] [Related]
11. Yeast genetic screen reveals novel therapeutic strategy for ALS.
Figley MD; Gitler AD
Rare Dis; 2013; 1():e24420. PubMed ID: 25002991
[TBL] [Abstract][Full Text] [Related]
12. Aggregation of the nucleic acid-binding protein TDP-43 occurs via distinct routes that are coordinated with stress granule formation.
Chen Y; Cohen TJ
J Biol Chem; 2019 Mar; 294(10):3696-3706. PubMed ID: 30630951
[TBL] [Abstract][Full Text] [Related]
13. The role of TDP-43 mislocalization in amyotrophic lateral sclerosis.
Suk TR; Rousseaux MWC
Mol Neurodegener; 2020 Aug; 15(1):45. PubMed ID: 32799899
[TBL] [Abstract][Full Text] [Related]
14. TDP-43 aggregation induced by oxidative stress causes global mitochondrial imbalance in ALS.
Zuo X; Zhou J; Li Y; Wu K; Chen Z; Luo Z; Zhang X; Liang Y; Esteban MA; Zhou Y; Fu XD
Nat Struct Mol Biol; 2021 Feb; 28(2):132-142. PubMed ID: 33398173
[TBL] [Abstract][Full Text] [Related]
15. Hyperphosphorylation as a defense mechanism to reduce TDP-43 aggregation.
Li HY; Yeh PA; Chiu HC; Tang CY; Tu BP
PLoS One; 2011; 6(8):e23075. PubMed ID: 21850253
[TBL] [Abstract][Full Text] [Related]
16. Altered TDP-43 Structure and Function: Key Insights into Aberrant RNA, Mitochondrial, and Cellular and Systemic Metabolism in Amyotrophic Lateral Sclerosis.
Jiang L; Ngo ST
Metabolites; 2022 Jul; 12(8):. PubMed ID: 36005581
[TBL] [Abstract][Full Text] [Related]
17. Nucleolin Rescues TDP-43 Toxicity in Yeast and Human Cell Models.
Peggion C; Massimino ML; Stella R; Bortolotto R; Agostini J; Maldi A; Sartori G; Tonello F; Bertoli A; Lopreiato R
Front Cell Neurosci; 2021; 15():625665. PubMed ID: 33912014
[TBL] [Abstract][Full Text] [Related]
18. "STRESSED OUT": The role of FUS and TDP-43 in amyotrophic lateral sclerosis.
Aksoy YA; Deng W; Stoddart J; Chung R; Guillemin G; Cole NJ; Neely GG; Hesselson D
Int J Biochem Cell Biol; 2020 Sep; 126():105821. PubMed ID: 32758633
[TBL] [Abstract][Full Text] [Related]
19. USP10 Inhibits Aberrant Cytoplasmic Aggregation of TDP-43 by Promoting Stress Granule Clearance.
Takahashi M; Kitaura H; Kakita A; Kakihana T; Katsuragi Y; Onodera O; Iwakura Y; Nawa H; Komatsu M; Fujii M
Mol Cell Biol; 2022 Mar; 42(3):e0039321. PubMed ID: 35007165
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-183-5p regulates TAR DNA-binding protein 43 neurotoxicity via SQSTM1/p62 in amyotrophic lateral sclerosis.
Kim HC; Zhang Y; King PH; Lu L
J Neurochem; 2023 Mar; 164(5):643-657. PubMed ID: 36527420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
